ArticleFrontiers in medicine2026
Combined PLR and VAS for patient self-perception in rheumatoid arthritis: a retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the independent and synergistic predictive value of platelet/lymphocyte ratio (PLR) and visual analogue scale (VAS) for multidimensional self-perception of patient (SPP) in rheumatoid arthritis (RA), and to support high-risk population stratification. Methods: A total of 708 RA patients were enrolled and categorized into four groups according to the median levels of PLR and VAS. Correlation and multivariate logistic regression analyses were adopted to evaluate their associations with SPP. Results: PLR and VAS were closely correlated with multidimensional SPP abnormalities. High VAS served as an independent risk factor for SPP deterioration. Combined high PLR and high VAS exhibited a prominent synergistic effect, greatly increasing the risk of impaired mental health and TCM spleen deficiency with dampness syndrome. Conclusion: Combined PLR and VAS assessment offers synergistic predictive value for SPP deterioration in RA. The dual-high phenotype can serve as a simple auxiliary marker for identifying high-risk RA patients to facilitate targeted monitoring and personalized management, with further prospective validation still required.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.